NCT06454084

Brief Summary

The first aim of this study is to create a cumulative dose-response curve for acetylcholine in men (low serum estrogen levels) to determine the lowest concentration with which we can induce a maximal vasodilation effect on the human gingiva. Furthermore, the second aim of this study is the characterization of the age-dependent effect of sex hormones on gingival blood flow, as well as of the gender differences by applying this concentration to premenopausal men and women with low and high estrogen levels, as well as to postmenopausal subjects.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 12, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

June 12, 2024

Status Verified

June 1, 2024

Enrollment Period

1.3 years

First QC Date

June 6, 2024

Last Update Submit

June 6, 2024

Conditions

Keywords

spreading vasodilationgingival microcirculationLSCI

Outcome Measures

Primary Outcomes (1)

  • 1. Blood flow change after applying the test solution

    The change in blood flow will be measured after applying the test solution

    19 minutes

Study Arms (1)

Acetylcholine 0,1 mg/mL and 1 mg/mL and 10 mg/mL

EXPERIMENTAL

Vasodilator solution is dropped on the labial surface of the lateral incisor, which penetrates into the gingival sulcus. In the dose-response study, 0,1 mg/mL, 1 mg/mL, and 10 mg/mL acetylcholine solution is dropped into the gingival sulcus, and every solution remains there for 2:30 minutes between them is always a 30-second long pause. In the second phase of the study, where the sex differences are monitored, 10 mg/mL acetylcholine solution is dropped into the gingival sulcus for 15 minutes

Drug: Acetylcholine Chloride

Interventions

Vasodilator solution

Acetylcholine 0,1 mg/mL and 1 mg/mL and 10 mg/mL

Eligibility Criteria

Age18 Years - 90 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailswomen and men
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy systemic and periodontal conditions

You may not qualify if:

  • systemic disease and medication
  • periodontal disease
  • smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department for Restorative Dentistry and Endodontics, Semmelweis University

Budapest, 1088, Hungary

Location

MeSH Terms

Conditions

Aneurysm

Interventions

Acetylcholine

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Biogenic AminesAminesOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

June 6, 2024

First Posted

June 12, 2024

Study Start

September 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

June 12, 2024

Record last verified: 2024-06

Locations